Research output
- 27 results
Search results
-
2017
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H. & Svensson, J., 2017 May 2, In: PLoS ONE. 12, 5, e0176760.Research output: Contribution to journal › Article › peer-review
Open Access -
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
Shahim, P., Blennow, K., Johansson, P., Svensson, J., Lista, S., Hampel, H., Andersson, L. C. & Zetterberg, H., 2017 Mar, In: NeuroMolecular Medicine.Research output: Contribution to journal › Article › peer-review
-
2016
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
Paterson, R. W., Heywood, W. E., Heslegrave, A. J., Magdalinou, N. K., Andreasson, U., Sirka, E., Bliss, E., Slattery, C. F., Toombs, J., Svensson, J., Johansson, P., Fox, N. C., Zetterberg, H., Mills, K. & Schott, J. M., 2016 Nov 15, In: Translational Psychiatry. 6, 11, p. 1-10 e952.Research output: Contribution to journal › Article › peer-review
Open Access -
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
Öhrfelt, A., Johansson, P., Wallin, A., Andreasson, U., Zetterberg, H., Blennow, K. & Svensson, J., 2016 Aug 10, In: Dementia and Geriatric Cognitive Disorders Extra. 6, 2, p. 283-94 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Heslegrave, A., Heywood, W., Paterson, R., Magdalinou, N., Svensson, J., Johansson, P., Öhrfelt, A., Blennow, K., Hardy, J., Schott, J., Mills, K. & Zetterberg, H., 2016, In: Molecular Neurodegeneration. 11, p. 1-7 3.Research output: Contribution to journal › Article › peer-review
Open Access -
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease
Horvath, I., Jia, X., Johansson, P., Wang, C., Moskalenko, R., Steinau, A., Forsgren, L., Wågberg, T., Svensson, J., Zetterberg, H. & Morozova-Roche, L. A., 2016, In: ACS Chemical Neuroscience. 7, 1, p. 34-39Research output: Contribution to journal › Article › peer-review
-
2015
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H. & Svensson, J., 2015, In: Neuroscience Letters. 609, p. 58-62Research output: Contribution to journal › Article › peer-review
-
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
Åberg, D., Johansson, P., Isgaard, J., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H., Åberg, N. D., Svensson, J. & Baker, L., 2015, In: Journal of Alzheimer's Disease. 48, 3, p. 637-646Research output: Contribution to journal › Article › peer-review
-
2014
Endokrina och diagnostiska aspekter på kognitiv svikt
Johansson, P., 2014, In: Neurologi i Sverige. 2, p. 30-34 2.Research output: Contribution to journal › Debate/Note/Editorial
Open AccessFile1152 Downloads (Pure) -
Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
Johansson, P., 2014, Conference paper Keystone . Vol. 20. (Conference paper keystone symposia ).Research output: Chapter in Book/Report/Conference proceeding › Paper in conference proceeding › peer-review
-
The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
Pannee, J., Törnqvist, U., Westerlund, A., Ingelsson, M., Lannfelt, L., Brinkmalm, G., Persson, R., Gobom, J., Svensson, J., Johansson, P., Zetterberg, H., Blennow, K. & Portelius, E., 2014, In: Neuroscience Letters. 573, p. 7-12Research output: Contribution to journal › Article › peer-review
-
2013
Endocrine and diagnostic aspects of cognitive impairment with special reference to Alzheimer's disease
Johansson, P., 2013 Apr 30, Göteborg: Göteborgs universitet.Research output: Thesis › Doctoral Thesis (compilation)
Open Access -
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
Johansson, P., Almqvist, E. G., Johansson, J.-O., Mattsson, N., Andreasson, U., Hansson, O., Wallin, A., Blennow, K., Zetterberg, H. & Svensson, J., 2013, In: PLoS ONE. 8, 11, e81989.Research output: Contribution to journal › Article › peer-review
Open AccessFile203 Downloads (Pure) -
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
Johansson, P., Almqvist, E. G., Johansson, J.-O., Mattsson, N., Hansson, O., Wallin, A., Blennow, K., Zetterberg, H. & Svensson, J., 2013, In: Psychoneuroendocrinology. 38, 7, p. 1058-1066Research output: Contribution to journal › Article › peer-review
-
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
Johansson, P., Aberg, D., Johansson, J.-O., Mattsson, N., Hansson, O., Ahrén, B., Isgaard, J., Aberg, N. D., Blennow, K., Zetterberg, H., Wallin, A. & Svensson, J., 2013, In: Psychoneuroendocrinology. 38, 9, p. 1729-1737Research output: Contribution to journal › Article › peer-review
-
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
Johansson, P., Åberg, D., Johansson, J.-O., Mattsson, N., Hansson, O., Ahrén, B., Isgaard, J., Åberg, N., Blennow, K., Zetterberg, H., Wallin, A. & Svensson, J., 2013.Research output: Contribution to conference › Poster › peer-review
-
The ELISA-Measured Increase in Cerebrospinal Fluid Tau that Discriminates Alzheimer's Disease from other Neurodegenerative Disorders is not Attributable to Differential Recognition of Tau Assembly Forms
O'Dowd, S. T., Ardah, M. T., Johansson, P., Lomakin, A., Benedek, G. B., Roberts, K. A., Cummins, G., El Agnaf, O. M., Svensson, J., Zetterberg, H., Lynch, T. & Walsh, D. M., 2013, In: Journal of Alzheimer's Disease. 33, 4, p. 923-928Research output: Contribution to journal › Article › peer-review
-
2012
Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study
Moverare-Skrtic, S., Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.-O., Zetterberg, H., Blennow, K. & Svensson, J., 2012, In: Experimental Gerontology. 47, 2, p. 179-182Research output: Contribution to journal › Article › peer-review
-
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer´s disease
Johansson, P., 2012.Research output: Contribution to conference › Other › peer-review
-
The determination of aggregated tau in solution and its potential as a tool for the diagnosis of tauopathies
O'Dowd, S. T., Johansson, P., Ardah, M. T., Roberts, K. A., Cummins, G., El Agnaf, O., Svensson, J., Zetterberg, H., Lynch, T. & Walsh, D. M., 2012, In: European Journal of Neurology. 19, Suppl. 1, p. 98-98Research output: Contribution to journal › Published meeting abstract › peer-review
-
2011
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Diagnostic Performance in a Homogeneous Mono-Center Population
Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.-O., Andreasson, U., Zetterberg, H., Blennow, K. & Svensson, J., 2011, In: Journal of Alzheimer's Disease. 24, 3, p. 537-546Research output: Contribution to journal › Article › peer-review
-
Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
Mattsson, N., Tabatabaei, S., Johansson, P., Hansson, O., Andreasson, U., Mansson, J.-E., Johansson, J.-O., Olsson, B., Wallin, A., Svensson, J., Blennow, K. & Zetterberg, H., 2011, In: NeuroMolecular Medicine. 13, 2, p. 151-159Research output: Contribution to journal › Article › peer-review
-
Discriminatory analysis of biochip-derived protein patterns in CSF and plasma in neurodegenerative diseases
Rosén, C., Mattsson, N., Johansson, P., Andreasson, U., Wallin, A., Hansson, O., Johansson, J.-O., Lamont, J., Svensson, J., Blennow, K. & Zetterberg, H., 2011, In: Frontiers in Aging Neuroscience. 3Research output: Contribution to journal › Article › peer-review
-
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women.
Johansson, P., Johansson, J.-O., Labrie, F., Mattsson, N., Hansson, O., Blennow, K., Zetterberg, H., Wallin, A., Ohlsson, C. & Svensson, J., 2011, In: Clinical Endocrinology. 75, p. 301-308Research output: Contribution to journal › Article › peer-review
-
2010
An enzyme activity as a potential biomarker for Alzheimer's disease.
Andreasson, U., Bjerke, M., Gobom, J., Hansson, O., Johansson, P., Svensson, J., Zetterberg, H. & Blennow, K., 2010, In: Alzheimer's & Dementia. 6, 4, p. S497–S498Research output: Contribution to journal › Published meeting abstract › peer-review
-
Convergence of chromogranin and amyloid metabolism in the brain.
Johansson, P., Mattsson, N., Hansson, O., Wallin, A., Johansson, J.-O., Andreasson, U., Andersen, O., Haghighi, S., Olsson, M., Stridsberg, M., Svensson, J., Blennow, K. & Zetterberg, H., 2010, In: Alzheimer's & Dementia. 6, 4, p. S511Research output: Contribution to journal › Published meeting abstract › peer-review
-
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
Mattsson, N., Johansson, P., Hansson, O., Wallin, A., Johansson, J.-O., Andreasson, U., Andersen, O., Haghighi, S., Olsson, M., Stridsberg, M., Svensson, J., Blennow, K. & Zetterberg, H., 2010, In: Journal of Alzheimer's Disease. 20, 4, p. 1039-1048Research output: Contribution to journal › Article › peer-review